Sign in
4

Changes in Ownership

VOLITIONRX LTD Filed Acc 0001477932-26-001096

Chief Scientific Officer acquired 149,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Micallef Jacob Vincent · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-26 Grant or award : show line 1 in the form +149,000 577,489 D
Loading xslF345X05/form4.xml…